ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for ...

SACRAMENTO, Calif.--(BUSINESS WIRE)--Insera Therapeutics, Inc. announced today that it has received Conformité Européenne (CE) Mark approval for its flagship product, the CLEAR Aspiration System, for ...

Results of EXTRACT-PE Trial presented at Vascular InterVentional Advances (VIVA) Annual Meeting “The Indigo Aspiration System has demonstrated tremendous potential to address patients with clot in ...

Please provide your email address to receive an email when new articles are posted on . Penumbra announced its aspiration system to treat pulmonary embolism has received clearance for an expanded ...

MIAMI, Dec. 11, 2024 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a Delaware corporation headquartered in Miami, Florida focused on improving the treatment success rate for acute ischemic stroke (AIS) ...

Launches Indigo® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical Officer Lightning™ 12 – Intelligent ...

Please provide your email address to receive an email when new articles are posted on . The new system (Indigo System Lightning 12) combines an aspiration catheter with an intelligent aspiration ...

The FDA has announced 510(k) clearance for expanded indication of the latest iteration of Penumbra's (NYSE:PEN +1.3%) Indigo Aspiration System, Lightning 12. As part of the Indigo Aspiration System, ...

HOUSTON - Feb. 22, 2017 - Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced the presentation of the results of the ASTER Trial, the first independent, prospective, ...

Following the FDA’s clearance earlier this year of its large-bore catheter for removing oxygen-blocking blood clots, Imperative Care is rolling out a new technique for treating stroke that combines ...